MIRM Mirum Pharmaceuticals Inc

USD 40.45 +0.05 ( +0.12)%
Icon

Mirum Pharmaceuticals Inc (MIRM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 40.45

+0.05 (+0.12)%

N/A

0.36M

USD 55.97(+38.38%)

USD 22.00 (-45.61%)

Icon

MIRM

Mirum Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 40.45
+0.05 ( +0.12)%

Mirum Pharmaceuticals Inc (MIRM) Stock Forecast

Show ratings and price targets of :
USD 55.97
(+38.38%)

Based on the Mirum Pharmaceuticals Inc stock forecast from 10 analysts, the average analyst target price for Mirum Pharmaceuticals Inc is USD 55.97 over the next 12 months. Mirum Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Mirum Pharmaceuticals Inc is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, Mirum Pharmaceuticals Inc’s stock price was USD 40.45. Mirum Pharmaceuticals Inc’s stock price has changed by +2.30% over the past week, +3.03% over the past month and +34.83% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...